- Home
- OSBC vs ABUS Comparison
OSBC vs ABUS Comparison
Compare OSBC & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSBC
- ABUS
- Stock Information
- Founded
- OSBC 1981
- ABUS 2005
- Country
- OSBC United States
- ABUS United States
- Employees
- OSBC N/A
- ABUS N/A
- Industry
- OSBC Major Banks
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- OSBC Finance
- ABUS Health Care
- Exchange
- OSBC Nasdaq
- ABUS Nasdaq
- Market Cap
- OSBC 708.1M
- ABUS 592.8M
- IPO Year
- OSBC N/A
- ABUS N/A
- Fundamental
- Price
- OSBC $14.78
- ABUS $3.15
- Analyst Decision
- OSBC Buy
- ABUS Strong Buy
- Analyst Count
- OSBC 5
- ABUS 4
- Target Price
- OSBC $20.80
- ABUS $5.50
- AVG Volume (30 Days)
- OSBC 243.3K
- ABUS 1.3M
- Earning Date
- OSBC 04-23-2025
- ABUS 05-01-2025
- Dividend Yield
- OSBC 1.62%
- ABUS N/A
- EPS Growth
- OSBC N/A
- ABUS N/A
- EPS
- OSBC 1.87
- ABUS N/A
- Revenue
- OSBC $271,799,000.00
- ABUS $6,171,000.00
- Revenue This Year
- OSBC $17.44
- ABUS $14.57
- Revenue Next Year
- OSBC $14.38
- ABUS $15.84
- P/E Ratio
- OSBC $7.90
- ABUS N/A
- Revenue Growth
- OSBC 0.81
- ABUS N/A
- 52 Week Low
- OSBC $13.26
- ABUS $2.63
- 52 Week High
- OSBC $19.46
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- OSBC 33.84
- ABUS 46.31
- Support Level
- OSBC $14.34
- ABUS $2.71
- Resistance Level
- OSBC $15.22
- ABUS $3.34
- Average True Range (ATR)
- OSBC 0.75
- ABUS 0.22
- MACD
- OSBC -0.03
- ABUS -0.01
- Stochastic Oscillator
- OSBC 23.19
- ABUS 48.89
About OSBC Old Second Bancorp Inc.
Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The Company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.